Early antibody therapy can induce long-lasting immunity to SHIV
Early antibody therapy can induce long-lasting immunity to SHIV
About this item
Full title
Author / Creator
Nishimura, Yoshiaki , Gautam, Rajeev , Chun, Tae-Wook , Sadjadpour, Reza , Foulds, Kathryn E. , Shingai, Masashi , Klein, Florian , Gazumyan, Anna , Golijanin, Jovana , Donaldson, Mitzi , Donau, Olivia K. , Plishka, Ronald J. , Buckler-White, Alicia , Seaman, Michael S. , Lifson, Jeffrey D. , Koup, Richard A. , Fauci, Anthony S. , Nussenzweig, Michel C. and Martin, Malcolm A.
Publisher
London: Nature Publishing Group UK
Journal title
Language
English
Formats
Publication information
Publisher
London: Nature Publishing Group UK
Subjects
More information
Scope and Contents
Contents
Early administration of broadly neutralizing antibodies in a macaque SHIV infection model is associated with very low levels of persistent viraemia, which leads to the establishment of T-cell immunity and resultant long-term infection control.
Antibodies fight HIV
No effective vaccine has yet been developed against the human immunodeficiency...
Alternative Titles
Full title
Early antibody therapy can induce long-lasting immunity to SHIV
Authors, Artists and Contributors
Author / Creator
Gautam, Rajeev
Chun, Tae-Wook
Sadjadpour, Reza
Foulds, Kathryn E.
Shingai, Masashi
Klein, Florian
Gazumyan, Anna
Golijanin, Jovana
Donaldson, Mitzi
Donau, Olivia K.
Plishka, Ronald J.
Buckler-White, Alicia
Seaman, Michael S.
Lifson, Jeffrey D.
Koup, Richard A.
Fauci, Anthony S.
Nussenzweig, Michel C.
Martin, Malcolm A.
Identifiers
Primary Identifiers
Record Identifier
TN_cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_5458531
Permalink
https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_5458531
Other Identifiers
ISSN
0028-0836,1476-4687
E-ISSN
1476-4687
DOI
10.1038/nature21435
